Evaluation of long-term clarithromycin treatment in adult Chinese patients with chronic rhinosinusitis without nasal polyps

ORL

Volumn 73, Issue 4, 2011, Pages 206-211

  Luo, Qing ^a,b   Chen, Fenghong ^a,b   Liu, Wenlong ^a,b   Li, Zuwang ^a,b   Xu, Rui ^a,b   Fan, Yunping ^c   Chen, Rong ^d   Xu, Yu ^e   Liu, Zheng ^f   Xu, Geng ^a,b   Fu, Qingling ^a,b   Zuo, Kejun ^a,b   Shi, Jianbo ^a,b   Li, Huabin ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d Zhongshan City Hospital   (China)

^e RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chronic rhinosinusitis; Inflammatory mediator; Macrolide; Nasal symptom; Quality of life; Without nasal polyps

Indexed keywords

CLARITHROMYCIN; INTERLEUKIN 8; MYELOPEROXIDASE;

ADULT; ARTICLE; CHINESE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFLAMMATION; LONG TERM CARE; MALE; NOSE POLYP; PRIORITY JOURNAL; QUALITY OF LIFE; RHINOMETRY; RHINOSINUSITIS; SCORING SYSTEM; SHORT FORM 36; TREATMENT DURATION;

ADULT; ANTI-BACTERIAL AGENTS; CHINA; CHRONIC DISEASE; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NASAL POLYPS; PREVALENCE; RHINITIS; SINUSITIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960263163     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000328342     Document Type: Article

References (20)

1. Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps Group: European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007; 1-136.
2. van Drunen CM, Reinartz S, Wigman J, Fokkens WJ: Inflammation in chronic rhinosinusitis and nasal polyposis. Immunol Allergy Clin North Am 2009; 29: 621-629.
3. Tan BK, Schleimer RP, Kern RC: Perspectives on the etiology of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 21-26.
4. Shinkai M, Henke MO, Rubin BK: Macrolide antibiotics as immunomodulatory medications: Proposed mechanisms of action. Pharmacol Ther 2008; 117: 393-405.
5. Takizawa H, Desaki M, Ohtoshi T, Kawasaki S, Kohyama T, Sato M, Tanaka M, Kasama T, Kobayashi K, Nakajima J, Ito K: Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 1997; 156: 266-271. (Pubitemid 27293200)
6. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H: Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000; 14: 143-148. (Pubitemid 30441214)
7. Cervin A, Wallwork B, Mackay-Sim A, Coman WB, Greiff L: Effects of long-term cla rithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis. Clin Physiol Funct Imaging 2009; 29: 136-142.
8. Verleden GM, Vanaudenaerde BM, Dupont LJ, van Raemdonck DE: Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 174: 566-570. (Pubitemid 44330550)
9. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A: A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116: 189-193. (Pubitemid 44383921)
10. Fan YP, Chen SL, Qu XJ, Zuo KJ, Li XM, Huang J, Xu G, Mi JP, Li HB: A lower prevalence of asthma among patients with chronic rhinosinusitis in southern China. J Allergy Clin Immunol 2011; 127: 520-522e1-e5.
11. Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, Wang DY, Desrosiers M, Liu Z: Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124: 478-484, 484e1-484e2.
12. Zuo KJ, Xu G, Shi JB, Wen WP, Chen HX, Xu R, Hu LJ, Liu LQ: Subjective and objective clinical outcome assessment on chronic rhinosinusitis following endoscopic sinus surgery (in Chinese). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008; 43: 7-12.
13. Riechelmann H, Deutschle T, Friemel E, Gross HJ, Bachem M: Biological markers in nasal secretions. Eur Respir J 2003; 21: 600-605. (Pubitemid 36432511)
14. Kalish LH, Arendts G, Sacks R, Craig JC: Topical steroids in chronic rhinosinusitis without polyps: A systematic review and meta- analysis. Otolaryngol Head Neck Surg 2009; 141: 674-683.
15. Parikh A, Scadding GK, Darby Y, Baker RC: Topical corticosteroids in chronic rhinosinusitis: A randomized, double-blind, placebo- controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001; 39: 75-79. (Pubitemid 32631617)
16. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF: Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with nonsevere asthma. Thorax 2008; 63: 784-790.
17. Cosío BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF, Adcock IM: Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med 2004; 170: 141-147. (Pubitemid 38925159)
18. Bhavsar P, Khorasani N, Hew M, Johnson M, Chung KF: Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma. Eur Respir J 2010; 35: 750-756.
19. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H: Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000; 14: 143-148. (Pubitemid 30441214)
20. Zhang N, van Zele T, Perez-Novo C, van Bruaene N, Holtappels G, DeRuyck N, van Cauwenberge P, Bachert C: Different types of Teffector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008; 122: 961-968.